Our top ten news from 25 January 2024 to 01 February 2024 (ranked according to popularity).

1 - ResMed Recovery Turns Into Hollywood Script

Wednesday 31 January 2024

More troubles for key competitor Philips/Respironics suggests there could be more momentum shifting in ResMed's favour

2 - ResMed Makes A Comeback

Monday 29 January 2024

ResMed's December quarter showed long-awaited margin improvement and relieved market fears of the impact of weight-loss drugs

3 - Uranium Week: Reassessing Uranium Prices

Tuesday 30 January 2024

Brokers have queued up to lift their longer-term uranium price forecasts just as the spot price sees its first weekly drop since November

4 - Spotlight On ASX-Listed Cannabis Companies

Wednesday 31 January 2024

Some cannabis gems are sprouting in the ASX weed patch, but they are hard to find in the haze of hype, Tim Boreham, Editor, The New Criterion reports

5 - Weekly Ratings, Targets, Forecast Changes - 25-01-24

Monday 29 January 2024

Weekly update on stockbroker recommendation, target price, and earnings forecast changes

6 - In Case You Missed It - BC Extra Upgrades & Downgrades - 25-01-24

Thursday 25 January 2024

A summary of the highlights from Broker Call Extra updates throughout the week past

7 - The Market In Numbers - 27 Jan 2024

Saturday 27 January 2024

Overviews in raw numbers and calculations that might assist investors with assessing trends and currents that might not be apparent from daily volatility and movements

8 - Woodside Energy: Head And Shoulders

Wednesday 31 January 2024

The Chartist reports a small head-and-shoulders pattern should keep momentum positive in the short term for Woodside Energy shares

9 - The Short Report - 25 Jan 2024

Thursday 25 January 2024

FNArena's weekly update on short positions in the Australian share market

10 - Charter Hall Looks Poised

Tuesday 30 January 2024

Michael Gable of Fairmont Equities is signaling momentum seems to have turned for Charter Hall shares, with a fresh Buy signal about to be triggered

All material published by FN Arena is the copyright of the publisher, unless otherwise stated. Reproduction in whole or in part is not permitted without written permission of the publisher.

© 2024 Acquisdata Pty Ltd., source FN Arena